These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9039875)

  • 21. Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.
    Horst HA; Schmitz N; Glinike C; Löffler H; Laufs R
    N Engl J Med; 1991 Jul; 325(2):132-3. PubMed ID: 1646961
    [No Abstract]   [Full Text] [Related]  

  • 22. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passively transfused hepatitis C antibody.
    Kudesia G; Price C; Clewley J
    Lancet; 1992 Nov; 340(8830):1291. PubMed ID: 1359346
    [No Abstract]   [Full Text] [Related]  

  • 24. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Bergman GE
    Lancet; 1995 Nov; 346(8985):1296-7. PubMed ID: 7475737
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up.
    Christie JM; Healey CJ; Watson J; Wong VS; Duddridge M; Snowden N; Rosenberg WM; Fleming KA; Chapel H; Chapman RW
    Clin Exp Immunol; 1997 Oct; 110(1):4-8. PubMed ID: 9353141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus and intravenous anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatitis C following administration of intravenous immunoglobulins].
    Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
    Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Immunoglobulins for intravenous use and hepatitis C viral transmission.
    Slade HB
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):613-9. PubMed ID: 8556510
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of immune globulin on the prevention of experimental hepatitis C virus infection.
    Krawczynski K; Alter MJ; Tankersley DL; Beach M; Robertson BH; Lambert S; Kuo G; Spelbring JE; Meeks E; Sinha S; Carson DA
    J Infect Dis; 1996 Apr; 173(4):822-8. PubMed ID: 8603959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin and hepatitis C virus: the British episode.
    Healey C; Chapel H
    Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446
    [No Abstract]   [Full Text] [Related]  

  • 31. Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
    Kessler C; Lusher J; Pierce GF; Pierce B; Koerper MA; Dickinson JC
    Lancet; 1995 Nov; 346(8985):1297-8. PubMed ID: 7475738
    [No Abstract]   [Full Text] [Related]  

  • 32. The safety of immune globulins.
    Tepper M; Gully P
    Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
    [No Abstract]   [Full Text] [Related]  

  • 33. Stability and transmission of hepatitis C virus in different anesthetic agents.
    Behrendt P; Doerrbecker J; Riebesehl N; Wilhelm C; Ciesek S; Erichsen TJ; Steinmann J; Ott M; Manns MP; Pietschmann T; Steinmann E
    Am J Infect Control; 2013 Oct; 41(10):942-3. PubMed ID: 23523523
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoglobulin transmits hepatitis C. True or false?
    Piazza M
    Hepatology; 1999 Jan; 29(1):299-300. PubMed ID: 9935341
    [No Abstract]   [Full Text] [Related]  

  • 35. Transmission of hepatitis after the administration of intravenous immunoglobulins.
    Rousell RH; Dobkin MB; Budinger MD; Louie RE
    Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous immunoglobulin and hepatitis C virus: the Boston episode.
    Schneider LC; Jonas MM; Baron MJ; Mast EF; Alter MJ; Schonberger LB; Lambert S; Coleman P; Bresee JS
    Clin Ther; 1996; 18 Suppl B():108-9. PubMed ID: 8930448
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.
    Lawlor E; Columb G
    N Engl J Med; 1999 Sep; 341(10):762; author reply 763. PubMed ID: 10475797
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus infections from contaminated 99mTc-sestamibi.
    Hung JC
    J Nucl Med; 2007 May; 48(5):847-8. PubMed ID: 17475974
    [No Abstract]   [Full Text] [Related]  

  • 39. Passive transfer of hepatitis antibodies during intravenous administration of immune globulin.
    Karna P; Murray DL; Valduss D; Mattarella N; Dyke JW; Maier GA
    J Pediatr; 1994 Sep; 125(3):463-5. PubMed ID: 8071759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of viruses related to hepatitis C virus by pasteurization in human plasma derivatives.
    Nowak T; Klockman U; Hilfenhaus J
    Biologicals; 1992 Mar; 20(1):83-5. PubMed ID: 1319182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.